We confirmed that the lead SNPs corresponding to the five genes—IRF1, IKZF1, SPI1, SH2B3 and LAT—were expression quantitative trait loci for these genes, allowing us to establish the directionality of the relationship between their expression and cancer risk and infer the direction of pharmacological modulation required. Here, SH2B3 is linked to cancer.